On March 11, 2020, The World Health Organization (WHO) declared the COVID-19 outbreak a pandemic. This unprecedented world-wide crisis can be combated only through global solidarity and coordination. Concerns are growing about the impact of COVID-19 on chronic diseases, including osteoporosis. The fall-out from COVID 19 on the Asia Pacific region – home to 4.5 …
The publishing of clinical practice guidelines aims to ensure the delivery of quality procedural standards for the diagnosis, treatment and management of a specific health condition or disease. According to a study published in the Public Library of Science in 2018, that systematically assessed clinical practice guidelines for the screening of osteoporosis globally, existing guidelines …
Consistency in osteoporosis guidelines pivotal to achieving optimal bone health outcomes Read More »
As COVID-19 continues to sweep the globe and distancing restrictions are further tightened, the effective use of telehealth services is more critical now than ever before. Unfortunately, the presence of osteoporosis doesn’t waver during a pandemic and it is therefore necessary to remain vigilant in the screening, diagnosis and management of the disease during this …
Dr Manju Chandran, a leader in the fields of Endocrinology and Bone Metabolism, is the Inaugural Chair of the Asia Pacific Consortium on Osteoporosis (APCO). Dr Chandran currently serves as a Senior Consultant Endocrinologist and Director of the Osteoporosis and Bone Metabolism Unit that she set up at Singapore General Hospital in 2007. After completing …
Did you know more than 200 million people worldwide live with osteoporosis? Or that Asia Pacific is home to 4.5 billion people and comprises 71 countries with vastly different healthcare systems? Asia’s population aged over 65 years is projected to more than quadruple by 2050, and further grow almost six-fold by 2100. Concerningly, by 2050, …
